Gel Antiperspirants for Hidradenitis Suppurativa: A Pilot Study

Main Article Content

Angela Rosenberg
Carter Gottlieb
Joseph Luba
William Abramovits
Clay Cockerell
Darrell Rigel
Ciaran Smythe

Keywords

Hidradenitis Suppurativa, treatment, hygiene, case series

Abstract

Introduction: Hidradenitis suppurativa (HS) is a chronic inflammatory condition predominantly affecting intertriginous areas. Despite its association with sweat, the role of deodorants and antiperspirants in HS remains poorly defined, with many patients avoiding their use due to concerns about irritation.


Methods: After experiencing personal clinical improvement with a gel-based aluminum salt antiperspirant, a dermatology resident began recommending similar gel-based aluminum salt antiperspirants to patients with Hurley stage I HS. Outcomes were tracked in seven patients. Additionally, a TikTok video was posted discussing gel antiperspirant use in HS, and user comments describing personal experiences were reviewed. A literature review was later conducted using PubMed, Scopus, and Web of Science.


Results: All seven patients experienced complete resolution of axillary HS lesions after initiating gel antiperspirants, including those who had failed previous treatments. Among 16 TikTok commenters who described their experiences, 94% reported disease improvement or clearance with gel or spray antiperspirants, while only 6% reported worsening with spray and/or gel antiperspirant. The literature revealed limited evidence, with three prior studies cautioning against antiperspirants despite some data suggesting spray and gel vehicles may be better tolerated than solid sticks.


Conclusion: Gel antiperspirants containing aluminum compounds appear safe, well-tolerated, and effective for managing or use in mild HS. These findings challenge prior concerns about antiperspirant use and suggest that product vehicle plays a key role in symptom control. Spray and gel formulations are preferable to solid sticks, and laser hair removal is favored over shaving. Prospective studies are warranted to formalize hygiene guidelines in HS management.

References

1. Alikhan A. Hidradenitis Suppurativa. JAMA Dermatol. 2016;152(6):736. doi:10.1001/jamadermatol.2016.0185

2. González-López MA. Hidradenitis suppurativa. Hidradenitis supurativa. Med Clin (Barc). 2024;162(4):182-189. doi:10.1016/j.medcli.2023.09.018

3. Kirby J, Kim K, Zivkovic M, et al. Uncovering the burden of hidradenitis suppurativa misdiagnosis and underdiagnosis: a machine learning approach. Front Med Technol. 2024;6:1200400. Published 2024 Mar 25. doi:10.3389/fmedt.2024.1200400

4. Bukvić Mokos Z, Miše J, Balić A, Marinović B. Understanding the Relationship Between Smoking and Hidradenitis Suppurativa. Acta Dermatovenerol Croat. 2020 Jul;28(1):9-13.

5. Zouboulis VA, Zouboulis KC, Zouboulis CC. Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing-A Molecular Meta-Analysis. Pharmaceutics. 2021;14(1):44. Published 2021 Dec 26. doi:10.3390/pharmaceutics14010044

6. Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: Current and emerging treatments. J Am Acad Dermatol. 2020;82(5):1061-1082. doi:10.1016/j.jaad.2019.08.089

7. Pathak GN, Makkar T, Pathak SS, Razi S, Wassef C, Rao B. Demographics and lifestyle factors of patients with hidradenitis suppurativa: An All of Us database analysis. JAAD Int. 2024;17:67-70. Published 2024 Sep 3. doi:10.1016/j.jdin.2024.08.002

8. Morgan WP, Leicester G. The role of depilation and deodorants in hidradenitis suppurativa. Arch Dermatol. 1982;118(2):101-102.

9. Edlich RF, Silloway KA, Rodeheaver GT, Cooper PH. Epidemiology, pathology, and treatment of axillary hidradenitis suppurativa. J Emerg Med. 1986;4(5):369-378. doi:10.1016/0736-4679(86)90214-3

10. Teerasumran P, Velliou E, Bai S, Cai Q. Deodorants and antiperspirants: New trends in their active agents and testing methods. Int J Cosmet Sci. 2023;45(4):426-443. doi:10.1111/ics.12852

11. Cutler B, Hagstrom E, Greiling TM. Deodorant/antiperspirant use and hair removal practices for hidradenitis suppurativa: recommendations from a single-center survey. Int J Womens Dermatol. 2023;9(1):e028. Published 2023 Jan 10. doi:10.1097/JW9.0000000000000028

12. Lauro W, Capasso G, Fabbrocini G, Marasca C. Hair removal and deodorants in hidradenitis suppurativa: An online survey on patients' habits. J Cosmet Dermatol. 2023;22(2):692-695. doi:10.1111/jocd.15373

13. Woolery-Lloyd H, Valins W. Aluminum chloride hexahydrate in a salicylic Acid gel: a novel topical agent for hyperhidrosis with decreased irritation. J Clin Aesthet Dermatol. 2009;2(6):28-31.

14. Shelley WB, Hurley HJ Jr. Studies on topical antiperspirant control of axillary hyperhidrosis. Acta Derm Venereol. 1975;55(4):241-260.

15. Musicante MJ, Cohen DE, Milam EC. Axillary Contact Dermatitis: An Update on Potential Allergens and Management. Cutis. 2024;113(1):35-42. doi:10.12788/cutis.0930

16. Innocenzi D, Lupi F, Bruni F, Frasca M, Panetta C, Milani M. Efficacy of a new aluminium salt thermophobic foam in the treatment of axillary and palmar primary hyperhidrosis: a pilot exploratory trial. Curr Med Res Opin. 2005;21(12):1949-1953. doi:10.1185/030079905X74899

17. Hosp C, Hamm H. Safety of available and emerging drug therapies for hyperhidrosis. Expert Opin Drug Saf. 2017;16(9):1039-1049. doi:10.1080/14740338.2017.1354983

18. Hoffmann KF, Wiesner A, Steinhauer S, Riedel S. Insights on the Lewis Superacid Al(OTeF5 )3 : Solvent Adducts, Characterization and Properties. Chemistry. 2022;28(57):e202201958. doi:10.1002/chem.202201958

19. Pariser DM, Ballard A. Topical therapies in hyperhidrosis care. Dermatol Clin. 2014;32(4):485-490. doi:10.1016/j.det.2014.06.008

20. Lenefsky M, Rice ZP. Hyperhidrosis and its impact on those living with it. Am J Manag Care. 2018;24(23 Suppl):S491-S495.

21. Mojumdar EH, Sparr E. The effect of pH and salt on the molecular structure and dynamics of the skin. Colloids Surf B Biointerfaces. 2021;198:111476. doi:10.1016/j.colsurfb.2020.111476

22. Scala E, Cacciapuoti S, Garzorz-Stark N, et al. Hidradenitis Suppurativa: Where We Are and Where We Are Going. Cells. 2021;10(8):2094. Published 2021 Aug 15. doi:10.3390/cells10082094

Most read articles by the same author(s)

<< < 1 2 3 4 5 6 > >>